Ilya M. Swanson

Ilya M. Swanson is a Research Technologist with the Mayo Clinic Vaccine Research Group. He has over four years of experience conducting immunological cell and serum-based research. Ilya received his B.S. degree in Environmental Science, Policy, and Management from the University of Minnesota with an emphasis on Policy, Planning, Law, and Society.

Richard B. Kennedy

Richard B. Kennedy, Ph. D., is a Professor of Medicine and the Co-Director of the Mayo Clinic Vaccine Research Group. Dr. Kennedy has over 120 peer-reviewed publications in journals including Lancet Infectious Diseasesthe Journal of Infectious Diseases, and Frontiers in Immunology. Richard received his B.S.  in Microbiology from Brigham Young University and his Ph.D. in Immunology from Mayo Clinic with postdoctoral training in immunogenetics and vaccinology.

Inna G. Ovsyannikova

Inna Ovsyannikova is the Director of Laboratory-based Studies for the Mayo Clinic Vaccine Research Group and a Professor of Medicine at Mayo Clinic. She has published over 220 peer-reviewed scientific manuscripts and 15 books/book chapters. Inna received her Ph.D. degree from the Ilya Mechnikov Research Institute for Vaccines and Sera in Moscow, Russia. She completed her postdoctoral training at the University of Virginia and has two fellowships in Clinical Pharmacology and Vaccinology at Mayo Clinic.

Gregory A. Poland

Gregory A. Poland, M.D., is a world-renowned physician-scientist currently serving as founding director of Mayo Clinic’s Vaccine Research Group. He has been awarded over $200 million in competitive extramural research funding. Gregory has published over 650 professional papers and/or book chapters. He received his medical degree from the Southern Illinois University School of Medicine in Springfield, Illinois, and completed his residency and advanced post-graduate work at the University of Minnesota.

Read This Article

No. 4 Maintaining Productivity and Safety During the SARS-COV-2 Pandemic: Insight from a Vaccine Research Laboratory